Share This Page
Drug Price Trends for NDC 60505-2673
✉ Email this page to a colleague
Average Pharmacy Cost for 60505-2673
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ARIPIPRAZOLE 5 MG TABLET | 60505-2673-08 | 0.09861 | EACH | 2025-12-17 |
| ARIPIPRAZOLE 5 MG TABLET | 60505-2673-03 | 0.09861 | EACH | 2025-12-17 |
| ARIPIPRAZOLE 5 MG TABLET | 60505-2673-08 | 0.09925 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 60505-2673
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| ARIPIPRAZOLE 5MG TAB | Golden State Medical Supply, Inc. | 60505-2673-03 | 30 | 42.60 | 1.42000 | 2023-06-16 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 60505-2673
Introduction
The pharmaceutical landscape is dynamic, with drug-specific market trends influenced by regulatory environments, manufacturing capabilities, therapeutic demand, and competitive innovations. This article offers a comprehensive market analysis and price projection for the drug identified by National Drug Code (NDC) 60505-2673, a product within the biopharmaceutical and specialty drug segment. Our focus is on providing actionable insights designed for industry stakeholders, including manufacturers, investors, payers, and healthcare providers.
Drug Profile and Therapeutic Context
The NDC 60505-2673 corresponds to [Drug Name], an [indication-specific description], developed by [Manufacturer]. The drug is classified under [drug class or therapeutic category], targeting [specific disease or condition], with a mechanism of action that involves [brief mechanistic summary].
Given its approval date of [Year], and data sources from [FDA, EMA, or other regulatory bodies], the drug has achieved a notable but niche market position, primarily serving [patient demographic, geographic regions, or specialized healthcare settings].
Regulatory and Patent Landscape
Regulatory Approvals:
The drug obtained FDA approval in [Year], with indications expanding to include [additional indications if any]. The presence of accelerated approval pathways or orphan drug designations impacts market access and pricing strategies.
Patent Status:
The primary patent for NDC 60505-2673 expires in [Year], with secondary patents or exclusivities granted until [Year]. Patent expiration typically triggers increased competition from biosimilars or generics, influencing market share and pricing.
Regulatory Challenges and Opportunities:
Regulatory hurdles, including post-marketing surveillance and potential label expansions, impact commercialization timelines. The potential for follow-on biosimilars or generics entering the market due to patent expirations is significant.
Market Landscape and Competitive Dynamics
Current Market Size:
As of 2022, the global market for [therapeutic area] was valued at approximately $X billion, with the segment for [specific indication or class] accounting for $Y billion. The market is projected to grow at a CAGR of Z%, driven by increasing prevalence of [disease], unmet medical needs, and new treatment modalities.
Key Competitors:
Major players include [competitor names], each with comparable or alternative therapies such as [drugs A, B, C]. The market share distribution indicates [brand dominance, emerging competitors]. The emergence of biosimilars in the future cycles is likely to reshape the competitive landscape.
Market Penetration and Adoption:
Adoption rates are influenced by factors such as clinical efficacy, safety profile, treatment adherence, and reimbursement conditions. Key markets include the US, Europe, and Japan, with varying levels of access driven by healthcare policies.
Pricing Trends and Reimbursement Landscape:
Pricing strategies now mirror value-based models, with discounts, rebates, and alternative financing options. Payers are increasingly adopting outcome-based reimbursement, especially for high-cost biologics.
Price Trends and Forecast
Historical Price Data:
Since launch, the wholesale acquisition cost (WAC) for NDC 60505-2673 has been approximately $X per dose/unit, with list prices reaching $Y in certain markets. In the US, net prices post-rebates are typically 20-30% lower than list prices, reflecting the negotiation power of payers.
Factors Influencing Price Dynamics:
- Patent expiration: Anticipated generics/biosimilars entry could reduce prices by 30-50% over 3-5 years.
- Market penetration: Increasing adoption tends to stabilize prices initially before competition drives reductions.
- Regulatory and policy changes: Legislation promoting biosimilar substitution can accelerate downward pricing pressure.
- Manufacturing costs: Advances in bioprocessing improve efficiency, potentially lowering production costs and supporting price reductions.
Projected Price Trajectory (Next 5-10 Years):
- Short-term (1-2 years): Stable prices due to patent protection and limited competition. Price increases aligned with inflation (~2-3%).
- Mid-term (3-5 years): Introduction of biosimilars or generics may cause a 20-40% reduction in list prices. Expect median prices around $X-Y per dose/unit.
- Long-term (6-10 years): Market stabilization with further pricing adjustments, potentially reaching $Z or lower, contingent on market uptake and patent challenges.
Key Market Drivers and Risks
Drivers:
- Rising prevalence of the targeted condition.
- Expanding indications and evolving treatment guidelines favoring this therapy.
- Increased reimbursement and insurance coverage.
- Advances in delivery mechanisms improving patient compliance.
Risks:
- Patent expiration leading to market saturation.
- Emergence of superior therapies or disruptive technologies.
- Regulatory changes restricting pricing and reimbursement.
- Market access barriers in emerging regions.
Strategic Recommendations
- Invest in Biosimilar Development: With patent expiry approaching, developing biosimilar versions could capture value from price reductions.
- Value-Based Contracting: Engage payers early to establish outcome-linked reimbursement models, safeguarding revenues amid pricing pressures.
- Global Market Expansion: Focus on emerging markets where regulatory barriers are lower and demand is growing, often at more favorable price points.
- Clinical Differentiation: Invest in personalized medicine and combination therapies to enhance clinical value, enabling premium pricing in selective markets.
Conclusion
NDC 60505-2673 operates in a highly competitive, evolving environment characterized by regulatory milestones, patent expiries, and burgeoning biosimilar markets. Its current valuation sustains due to clinical utility, but future price trajectories will largely depend on patent dynamics, regulatory pathways, and competitive innovations. Stakeholders should align strategic investments around impending market shifts, harnessing opportunities for differentiation and cost-effective access.
Key Takeaways
- The current market valuation of NDC 60505-2673 benefits from patent exclusivity, supporting stable pricing in the short term.
- Anticipated biosimilar and generic entry post-patent expiration pose significant downward pressure, with potential price reductions of up to 50%.
- Market growth remains driven by increasing disease prevalence and expanding indications, though competitive dynamics vary globally.
- Developing biosimilars and engaging in outcome-based contracts represent vital strategies for maximizing value amid price pressures.
- Political and regulatory environments will profoundly influence price trajectories; proactive engagement is essential.
FAQs
1. When is the patent for NDC 60505-2673 set to expire?
The primary patent is projected to expire in [Year], after which biosimilars and generics are likely to enter the market, impacting pricing.
2. What is the typical price range for this drug currently?
Current list prices approximate $Y per dose/unit, with net prices post-rebates estimated at around $X-Y. Prices vary depending on geographic markets and payer negotiations.
3. How will biosimilar entries affect the market for NDC 60505-2673?
Biosimilar introduction is expected to reduce prices by 30-50%, increasing market competition and possibly reducing the original product's market share unless differentiation strategies are employed.
4. Which regions present the most promising growth opportunities?
Emerging markets in Asia, Latin America, and parts of Europe show high growth potential due to increasing disease burden and improving healthcare infrastructure.
5. What are the main factors influencing future price reductions?
Patent expiration, biosimilar development, regulatory changes, payer policies favoring cost containment, and manufacturing cost efficiencies will primarily influence future pricing trends.
Sources:
- FDA Drug Database. [URL or specific database accessed]
- IMS Health Market Reports. [URL, date]
- Industry analyst reports on biologic and biosimilar markets.
- Patent Office records for [Country/Region].
- Healthcare policy publications and reimbursement guidelines.
More… ↓
